Cell & Gene Therapy
The rise of Cell & Gene Therapy and other Advanced Therapy Medicinal Products (ATMP) heralds a new era in healthcare. The ability to target DNA or RNA inside or outside the body and potentially modify genetic material to provide the antibodies needed to fight diseases has created an increased interest in how this technology can be manufactured and commercialised. Especially when ATMPs are so patient centric and delivered at such a high cost.
Scitech’s team of bioprocess engineers, process architects and engineering designers address these challenges by focusing on Good Manufacturing Practice (GMP). The team is able to deliver and oversee every stage of the project to ensure everything from the design of a facility to the selection of hardware and software is geared towards meeting all regulations and built to be scalable. With a focus in the biological sector, Scitech has built a team of thought leaders and industry experts that deliver tailored projects that are compliant, cost effective and flexible.
Read more
Card Text
Card CTA Text
Our work
Scitech & AstraZeneca
Scitech is partnering with AstraZeneca on the design, engineering, testing and project management of their new SPP6 facility.
SPP6 will continue and expand the increased demand for the manufacturing of Zoladex, a unique injectable treatment originally for patients with prostate cancer, now also administered to treat breast cancer and endometriosis.
Learn moreAmazing Project...
Ea ubique voluptaria sit, ea partem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore
Pscitech ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore ma ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod
Learn more